Rheumatoid Arthritis Recruiting Phase Trials for Golimumab (DB06674)

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis(RA) / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03729349Golimumab for Adherence in Rheumatoid Arthritis
NCT04188249Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis
NCT01965132Korean College of Rheumatology Biologics Registry